ATE460951T1 - Freisetzungssysteme zur behandlung von restenose und anastomotischer intimaler hyperplasie - Google Patents
Freisetzungssysteme zur behandlung von restenose und anastomotischer intimaler hyperplasieInfo
- Publication number
- ATE460951T1 ATE460951T1 AT01905081T AT01905081T ATE460951T1 AT E460951 T1 ATE460951 T1 AT E460951T1 AT 01905081 T AT01905081 T AT 01905081T AT 01905081 T AT01905081 T AT 01905081T AT E460951 T1 ATE460951 T1 AT E460951T1
- Authority
- AT
- Austria
- Prior art keywords
- restenosis
- treatment
- release systems
- intimal hyperplasia
- anastomotic intimal
- Prior art date
Links
- 206010020718 hyperplasia Diseases 0.000 title abstract 2
- 208000037803 restenosis Diseases 0.000 title 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 2
- 230000006378 damage Effects 0.000 abstract 2
- 238000012377 drug delivery Methods 0.000 abstract 2
- 208000014674 injury Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000012867 bioactive agent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/225—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/145—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
- A61L2300/622—Microcapsules
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17808700P | 2000-01-25 | 2000-01-25 | |
PCT/US2001/002563 WO2001054748A1 (en) | 2000-01-25 | 2001-01-25 | Delivery systems for treatment of restenosis and anastomotic intimal hyperplasia |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE460951T1 true ATE460951T1 (de) | 2010-04-15 |
Family
ID=22651126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01905081T ATE460951T1 (de) | 2000-01-25 | 2001-01-25 | Freisetzungssysteme zur behandlung von restenose und anastomotischer intimaler hyperplasie |
Country Status (8)
Country | Link |
---|---|
US (2) | US6730313B2 (de) |
EP (1) | EP1250166B1 (de) |
JP (1) | JP2003520830A (de) |
AT (1) | ATE460951T1 (de) |
AU (1) | AU775590B2 (de) |
CA (1) | CA2396628A1 (de) |
DE (1) | DE60141567D1 (de) |
WO (1) | WO2001054748A1 (de) |
Families Citing this family (120)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU716005B2 (en) * | 1995-06-07 | 2000-02-17 | Cook Medical Technologies Llc | Implantable medical device |
US20030199425A1 (en) * | 1997-06-27 | 2003-10-23 | Desai Neil P. | Compositions and methods for treatment of hyperplasia |
US6607751B1 (en) * | 1997-10-10 | 2003-08-19 | Intellipharamaceutics Corp. | Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum |
US20020188037A1 (en) * | 1999-04-15 | 2002-12-12 | Chudzik Stephen J. | Method and system for providing bioactive agent release coating |
DE69901927T2 (de) | 1998-04-27 | 2002-10-10 | Surmodics, Inc. | Bioaktive wirkstoffe freisetzende beschichtungen |
JP2001204075A (ja) * | 2000-01-24 | 2001-07-27 | Kddi Corp | 無線パケットチャネルを動的に割り当てる移動通信システム |
CA2396628A1 (en) * | 2000-01-25 | 2001-08-02 | Edwards Lifesciences Corporation | Delivery systems for treatment of restenosis and anastomotic intimal hyperplasia |
US7144729B2 (en) | 2000-09-01 | 2006-12-05 | Dfb Pharmaceuticals, Inc. | Methods and compositions for tissue regeneration |
US7261735B2 (en) * | 2001-05-07 | 2007-08-28 | Cordis Corporation | Local drug delivery devices and methods for maintaining the drug coatings thereon |
US6534693B2 (en) * | 2000-11-06 | 2003-03-18 | Afmedica, Inc. | Surgically implanted devices having reduced scar tissue formation |
US20040241211A9 (en) * | 2000-11-06 | 2004-12-02 | Fischell Robert E. | Devices and methods for reducing scar tissue formation |
US20040018228A1 (en) * | 2000-11-06 | 2004-01-29 | Afmedica, Inc. | Compositions and methods for reducing scar tissue formation |
US6565601B2 (en) * | 2000-11-15 | 2003-05-20 | Micro Therapeutics, Inc. | Methods for vascular reconstruction of diseased arteries |
DK2314293T3 (en) | 2001-01-16 | 2017-04-18 | Vascular Therapies Llc | IMPLANTABLE DEVICE CONTAINING RESORBABLE MATERIAL MATERIAL AND RAPAMYCINE FOR PREVENTION OR TREATMENT OF VASCULOPROLIFERATIVE DISEASES |
US20070027535A1 (en) * | 2005-07-28 | 2007-02-01 | Cook Incorporated | Implantable thromboresistant valve |
US8038708B2 (en) * | 2001-02-05 | 2011-10-18 | Cook Medical Technologies Llc | Implantable device with remodelable material and covering material |
DE10115740A1 (de) | 2001-03-26 | 2002-10-02 | Ulrich Speck | Zubereitung für die Restenoseprophylaxe |
US7396582B2 (en) | 2001-04-06 | 2008-07-08 | Advanced Cardiovascular Systems, Inc. | Medical device chemically modified by plasma polymerization |
FI20010898A0 (fi) * | 2001-04-30 | 2001-04-30 | Ylae Herttuala Seppo | Ekstrasellulaarinen superoksididismutaasi (EC-SOD) geeniterapia restenoosoin ehkäisemiseksi |
US6656506B1 (en) * | 2001-05-09 | 2003-12-02 | Advanced Cardiovascular Systems, Inc. | Microparticle coated medical device |
GB0113697D0 (en) * | 2001-06-06 | 2001-07-25 | Smith & Nephew | Fixation devices for tissue repair |
US7195640B2 (en) * | 2001-09-25 | 2007-03-27 | Cordis Corporation | Coated medical devices for the treatment of vulnerable plaque |
DE10150995A1 (de) | 2001-10-08 | 2003-04-10 | Biotronik Mess & Therapieg | Implantat mit proliferationshemmender Substanz |
US7488313B2 (en) | 2001-11-29 | 2009-02-10 | Boston Scientific Scimed, Inc. | Mechanical apparatus and method for dilating and delivering a therapeutic agent to a site of treatment |
DE10216971A1 (de) * | 2002-04-16 | 2003-10-30 | Lothar Sellin | Medizinisches Implantat, vorzugsweise Stent und Verfahren zu dessen Herstellung |
US7519418B2 (en) | 2002-04-30 | 2009-04-14 | Boston Scientific Scimed, Inc. | Mechanical apparatus and method for dilating and delivering a therapeutic agent to a site of treatment |
JP2006503605A (ja) * | 2002-04-30 | 2006-02-02 | フイット バイオテク オーワイジェイ ピーエルシー | 医療装置 |
AU2003234670B2 (en) * | 2002-05-24 | 2010-06-10 | Angiotech International Ag | Compositions and methods for coating medical implants |
US8313760B2 (en) | 2002-05-24 | 2012-11-20 | Angiotech International Ag | Compositions and methods for coating medical implants |
US6835387B2 (en) | 2002-06-11 | 2004-12-28 | Scimed Life Systems, Inc. | Sustained release of superoxide dismutase mimics from implantable or insertable medical devices |
JP4265888B2 (ja) * | 2002-06-12 | 2009-05-20 | 株式会社リコー | 画像形成装置 |
US20030232087A1 (en) * | 2002-06-18 | 2003-12-18 | Lawin Laurie R. | Bioactive agent release coating with aromatic poly(meth)acrylates |
US7097850B2 (en) * | 2002-06-18 | 2006-08-29 | Surmodics, Inc. | Bioactive agent release coating and controlled humidity method |
DE10244847A1 (de) | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
EP1549253A4 (de) * | 2002-09-26 | 2010-11-03 | Endovascular Devices Inc | Gerät und verfahren zur abgabe von mitomycin durch ein freisetzendes biokompatibles implantierbares medizinprodukt |
US8034361B2 (en) * | 2002-11-12 | 2011-10-11 | Advanced Cardiovascular Systems, Inc. | Stent coatings incorporating nanoparticles |
US20040209361A1 (en) * | 2003-04-18 | 2004-10-21 | Hemperly John J. | UV-cross-linked PVA-based polymer particles for cell culture |
US20040209360A1 (en) * | 2003-04-18 | 2004-10-21 | Keith Steven C. | PVA-based polymer coating for cell culture |
US20040213770A1 (en) * | 2003-04-22 | 2004-10-28 | Endobionics, Inc. | Methods and systems for treating ischemic cardiac and other tissues |
WO2004098697A1 (en) * | 2003-04-29 | 2004-11-18 | Neal Scott | Mechanical apparatus and method for dilating and delivering a therapeutic agent |
US8021680B2 (en) * | 2003-05-02 | 2011-09-20 | Surmodics, Inc. | Controlled release bioactive agent delivery device |
US8246974B2 (en) * | 2003-05-02 | 2012-08-21 | Surmodics, Inc. | Medical devices and methods for producing the same |
CA2529984C (en) | 2003-06-26 | 2012-09-25 | Isa Odidi | Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors |
US7169404B2 (en) * | 2003-07-30 | 2007-01-30 | Advanced Cardiovasular Systems, Inc. | Biologically absorbable coatings for implantable devices and methods for fabricating the same |
AU2004291062A1 (en) * | 2003-11-10 | 2005-06-02 | Angiotech International Ag | Medical implants and anti-scarring agents |
AU2004293071A1 (en) * | 2003-11-20 | 2005-06-09 | Angiotech International Ag | Polymer compositions and methods for their use |
US20050131513A1 (en) * | 2003-12-16 | 2005-06-16 | Cook Incorporated | Stent catheter with a permanently affixed conductor |
US20060083772A1 (en) * | 2004-04-06 | 2006-04-20 | Dewitt David M | Coating compositions for bioactive agents |
WO2005097228A2 (en) * | 2004-04-06 | 2005-10-20 | Surmodics, Inc. | Coating compositions for bioactive agents |
US7771740B2 (en) * | 2004-07-19 | 2010-08-10 | Boston Scientific Scimed, Inc. | Medical devices containing copolymers with graft copolymer endblocks for drug delivery |
US20060024361A1 (en) * | 2004-07-28 | 2006-02-02 | Isa Odidi | Disintegrant assisted controlled release technology |
US10624858B2 (en) * | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
US8110211B2 (en) * | 2004-09-22 | 2012-02-07 | Advanced Cardiovascular Systems, Inc. | Medicated coatings for implantable medical devices including polyacrylates |
US20060115454A1 (en) * | 2004-10-15 | 2006-06-01 | Linda Couto | Therapeutic RNAi agents for treating restenosis |
CA2526541C (en) * | 2004-12-01 | 2013-09-03 | Tyco Healthcare Group Lp | Novel biomaterial drug delivery and surface modification compositions |
US8263105B2 (en) * | 2004-12-01 | 2012-09-11 | Tyco Healthcare Group Lp | Biomaterial drug delivery and surface modification compositions |
US20060127443A1 (en) * | 2004-12-09 | 2006-06-15 | Helmus Michael N | Medical devices having vapor deposited nanoporous coatings for controlled therapeutic agent delivery |
WO2006086681A2 (en) * | 2005-02-09 | 2006-08-17 | Beth Israel Deaconess Medical Center, Inc. | Methods of inhibiting smooth muscle cell migration and proliferation |
WO2006099020A2 (en) * | 2005-03-09 | 2006-09-21 | The University Of Tennessee Research Foundation | Barrier stent and use thereof |
US20070172520A1 (en) * | 2005-11-18 | 2007-07-26 | University Of South Florida | Immunotargeting of Nonionic Surfactant Vesicles |
US20070196423A1 (en) * | 2005-11-21 | 2007-08-23 | Med Institute, Inc. | Implantable medical device coatings with biodegradable elastomer and releasable therapeutic agent |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
US20070160642A1 (en) * | 2006-01-12 | 2007-07-12 | Pacetti Stephen D | Implantable medical devices coated with a polymer-bound superoxide dismutase mimic |
US20070224235A1 (en) * | 2006-03-24 | 2007-09-27 | Barron Tenney | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8187620B2 (en) * | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US8785382B2 (en) * | 2006-04-03 | 2014-07-22 | Abbott Cardiovascular Systems Inc. | Lipid therapy |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
US20070264303A1 (en) * | 2006-05-12 | 2007-11-15 | Liliana Atanasoska | Coating for medical devices comprising an inorganic or ceramic oxide and a therapeutic agent |
US8703167B2 (en) * | 2006-06-05 | 2014-04-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug |
CA2656179A1 (en) * | 2006-06-21 | 2007-12-27 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for joining non-conjoined lumens |
US8608760B2 (en) * | 2006-06-21 | 2013-12-17 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for joining non-conjoined lumens |
US8197499B2 (en) * | 2006-06-21 | 2012-06-12 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for joining non-conjoined lumens |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
JP2009542359A (ja) * | 2006-06-29 | 2009-12-03 | ボストン サイエンティフィック リミテッド | 選択的被覆部を備えた医療装置 |
EP2068757B1 (de) | 2006-09-14 | 2011-05-11 | Boston Scientific Limited | Medizinprodukte mit wirkstofffreisetzender beschichtung |
US20080294236A1 (en) * | 2007-05-23 | 2008-11-27 | Boston Scientific Scimed, Inc. | Endoprosthesis with Select Ceramic and Polymer Coatings |
US8431149B2 (en) * | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
US10092524B2 (en) * | 2008-06-11 | 2018-10-09 | Edge Therapeutics, Inc. | Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage |
US8002823B2 (en) * | 2007-07-11 | 2011-08-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
EP2187988B1 (de) * | 2007-07-19 | 2013-08-21 | Boston Scientific Limited | Endoprothese mit nicht verschmutzender oberfläche |
US8815273B2 (en) * | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
WO2009018340A2 (en) * | 2007-07-31 | 2009-02-05 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
US8480651B2 (en) | 2007-08-02 | 2013-07-09 | Covidien Lp | Cannula system |
JP2010535541A (ja) * | 2007-08-03 | 2010-11-25 | ボストン サイエンティフィック リミテッド | 広い表面積を有する医療器具用のコーティング |
US10558961B2 (en) | 2007-10-18 | 2020-02-11 | Wayne Fueling Systems Llc | System and method for secure communication in a retail environment |
US20090118813A1 (en) * | 2007-11-02 | 2009-05-07 | Torsten Scheuermann | Nano-patterned implant surfaces |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US20090118821A1 (en) * | 2007-11-02 | 2009-05-07 | Boston Scientific Scimed, Inc. | Endoprosthesis with porous reservoir and non-polymer diffusion layer |
US20090118818A1 (en) * | 2007-11-02 | 2009-05-07 | Boston Scientific Scimed, Inc. | Endoprosthesis with coating |
US20090118809A1 (en) * | 2007-11-02 | 2009-05-07 | Torsten Scheuermann | Endoprosthesis with porous reservoir and non-polymer diffusion layer |
US20090118812A1 (en) * | 2007-11-02 | 2009-05-07 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
CA2710002A1 (en) * | 2007-12-20 | 2009-07-09 | Tautona Group, L.P. | Compositions and methods for joining non-conjoined lumens |
WO2009131911A2 (en) | 2008-04-22 | 2009-10-29 | Boston Scientific Scimed, Inc. | Medical devices having a coating of inorganic material |
WO2009132176A2 (en) | 2008-04-24 | 2009-10-29 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
AU2009257230B2 (en) * | 2008-06-13 | 2015-05-28 | Smith & Nephew, Inc. | Fixation devices for tissue repair |
EP2303350A2 (de) | 2008-06-18 | 2011-04-06 | Boston Scientific Scimed, Inc. | Endoprothesen-beschichtung |
US8642063B2 (en) * | 2008-08-22 | 2014-02-04 | Cook Medical Technologies Llc | Implantable medical device coatings with biodegradable elastomer and releasable taxane agent |
US20100070013A1 (en) * | 2008-09-18 | 2010-03-18 | Medtronic Vascular, Inc. | Medical Device With Microsphere Drug Delivery System |
US8231980B2 (en) * | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
US8563037B2 (en) * | 2009-02-06 | 2013-10-22 | Tautona Group, L.P. | Compositions and methods for joining non-conjoined lumens |
US8071156B2 (en) * | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
US20100233266A1 (en) | 2009-03-13 | 2010-09-16 | Cleek Robert L | Articles and methods of treating vascular conditions |
US20100274352A1 (en) * | 2009-04-24 | 2010-10-28 | Boston Scientific Scrimed, Inc. | Endoprosthesis with Selective Drug Coatings |
US8287937B2 (en) * | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
EP2498763A4 (de) | 2009-11-09 | 2015-10-07 | Spotlight Technology Partners Llc | Hydrogele auf polysaccharidbasis |
US8795727B2 (en) | 2009-11-09 | 2014-08-05 | Spotlight Technology Partners Llc | Fragmented hydrogels |
EP2531208A4 (de) * | 2010-02-03 | 2013-07-03 | Univ Rochester | Behandlung fibrosevermittelter leiden mithilfe fibronectinbindender proteine und polypeptide |
JP5911435B2 (ja) * | 2010-02-22 | 2016-04-27 | エッジ セラピューティクス インコーポレイテッド | 脳の出血状態を治療するための方法及び組成物 |
AR081743A1 (es) | 2010-03-26 | 2012-10-17 | Philip Morris Prod | Fabricacion de capsulas de nucleo/caparazon de diferentes geometrias y tratamiento a partir de las mismas |
WO2012138854A1 (en) * | 2011-04-05 | 2012-10-11 | Edge Therapeutics | Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow |
KR101331326B1 (ko) * | 2011-05-25 | 2013-11-20 | 연세대학교 산학협력단 | 약물 방출 스텐트 및 그 제조방법 |
US9827401B2 (en) | 2012-06-01 | 2017-11-28 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
JP6549482B2 (ja) | 2012-06-01 | 2019-07-24 | サーモディクス,インコーポレイテッド | バルーンカテーテルをコーティングするための装置および方法 |
US20140249618A1 (en) * | 2013-02-18 | 2014-09-04 | Elutin, Inc. | Site specific drug delivery wraps, systems and methods of use thereof |
WO2014154804A1 (en) * | 2013-03-27 | 2014-10-02 | Centre Hospitalier Universitaire Vaudois (C.H.U.V) | Pharmaceutical formulation for use in the treatment and/or prevention of restenosis |
WO2016065245A1 (en) * | 2014-10-24 | 2016-04-28 | Incept, Llc | Extra luminal scaffold |
US11628466B2 (en) | 2018-11-29 | 2023-04-18 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US11819590B2 (en) | 2019-05-13 | 2023-11-21 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
CN110433334B (zh) * | 2019-08-27 | 2021-12-14 | 扬州大学 | 3d打印气管c形支架与杂化型支架的制备方法 |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4393041A (en) | 1980-04-25 | 1983-07-12 | International Minerals & Chemical Corp. | Fibrin binder/carrier for active biochemical agents |
US4532134A (en) | 1981-04-06 | 1985-07-30 | Malette William Graham | Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound |
US4708861A (en) | 1984-02-15 | 1987-11-24 | The Liposome Company, Inc. | Liposome-gel compositions |
US4937324A (en) | 1987-02-06 | 1990-06-26 | Zymogenetics, Inc. | Chromatographic purification of human proteins having anticoagulant and anti-inflammatory activity |
AT397203B (de) | 1988-05-31 | 1994-02-25 | Immuno Ag | Gewebeklebstoff |
US5137734A (en) | 1989-03-22 | 1992-08-11 | Dana Farber Cancer Institute | Angiogenic monoglycerides |
US5252213A (en) | 1989-06-20 | 1993-10-12 | University Of Washington | Dry dialysate composition |
US5527532A (en) | 1989-11-13 | 1996-06-18 | President And Fellows Of Harvard College | Extraluminal regulation of the growth and repair of tubular structures in vivo |
WO1991007154A1 (en) | 1989-11-13 | 1991-05-30 | President And Fellows Of Harvard College | EXTRALUMINAL REGULATION OF THE GROWTH AND REPAIR OF TUBULAR STRUCTURES ιIN VIVO |
US5318524A (en) | 1990-01-03 | 1994-06-07 | Cryolife, Inc. | Fibrin sealant delivery kit |
US5626863A (en) | 1992-02-28 | 1997-05-06 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
US5410016A (en) | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
CA2038596A1 (en) | 1990-10-17 | 1992-04-18 | Leonard Pinchuk | Antithrombogenic composition and methods of making same |
DE69132918T2 (de) | 1990-11-27 | 2002-10-31 | American National Red Cross, Washington | Gewebeabdeckung und wachstumsfaktor enthaltende verbindungen zur förderung beschleunigter wundheilung |
US5632986A (en) | 1991-05-09 | 1997-05-27 | The University Of Washington | Phospholipid-targeted thrombolytic agents |
SE9101853D0 (sv) | 1991-06-17 | 1991-06-17 | Jonas Wadstroem | Improved tissue ashesive |
EP0534178B1 (de) | 1991-09-27 | 2001-04-18 | Omrix Biopharmaceuticals S.A. | Verbesserter Gewebekleber, zubereitet aus Kryopräzipitat |
US5270047A (en) | 1991-11-21 | 1993-12-14 | Kauffman Raymond F | Local delivery of dipyridamole for the treatment of proliferative diseases |
EP0643839B1 (de) | 1992-01-15 | 1996-11-27 | University of Washington | Ein verfahren zur bestimmung des biologischen potentials eines ausgenählten karzinoms von einem patienten |
US5573934A (en) | 1992-04-20 | 1996-11-12 | Board Of Regents, The University Of Texas System | Gels for encapsulation of biological materials |
WO1993017669A1 (en) | 1992-02-28 | 1993-09-16 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
US5540912A (en) | 1992-03-30 | 1996-07-30 | Alza Corporation | Viscous suspensions of controlled-release drug particles |
US5650447A (en) | 1992-08-24 | 1997-07-22 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Nitric oxide-releasing polymers to treat restenosis and related disorders |
CN1091315A (zh) | 1992-10-08 | 1994-08-31 | E·R·斯奎布父子公司 | 血纤维蛋白封闭剂组合物及其使用方法 |
CZ281454B6 (cs) | 1992-11-23 | 1996-10-16 | Milan Mudr. Csc. Krajíček | Pomůcka pro nechirurgické uzavírání otvoru ve stěně cévy |
ES2122248T3 (es) | 1993-02-25 | 1998-12-16 | Zymogenetics Inc | Inhibicion de la hiperplasia de la intima que emplea anticuerpos de receptores del factor de crecimiento derivado de plaquetas. |
CA2158134C (en) | 1993-03-12 | 2010-05-04 | Hernan A. Nunez | Supplemented tissue sealant |
US6019993A (en) | 1993-03-30 | 2000-02-01 | Omrix Biopharmaceuticals S.A. | Virus-inactivated 2-component fibrin glue |
US5443827A (en) | 1993-05-03 | 1995-08-22 | President And Fellows Of Harvard College | Fibrin-targeted inhibitors of thrombin |
US5549904A (en) | 1993-06-03 | 1996-08-27 | Orthogene, Inc. | Biological adhesive composition and method of promoting adhesion between tissue surfaces |
US5398691A (en) | 1993-09-03 | 1995-03-21 | University Of Washington | Method and apparatus for three-dimensional translumenal ultrasonic imaging |
US5498531A (en) | 1993-09-10 | 1996-03-12 | President And Fellows Of Harvard College | Intron-mediated recombinant techniques and reagents |
US5470957A (en) | 1993-10-01 | 1995-11-28 | President And Fellows Of Harvard College | Immunoinhibitors of factor XIII |
WO1995016035A2 (en) | 1993-12-07 | 1995-06-15 | Genetics Institute, Inc. | Bmp-12, bmp-13 and tendon-inducing compositions thereof |
US5622843A (en) | 1993-12-30 | 1997-04-22 | Zymogenetics, Inc. | Phospholipid transfer proteins and DNA encoding them |
ATE241340T1 (de) | 1994-02-17 | 2003-06-15 | New York Blood Ct Inc | Biologische bioadhäsive präparate, die fibrinkleber und liposomen enthalten, verfahren für ihre herstellung und verwendung |
EP0759762A4 (de) | 1994-05-02 | 1999-09-01 | Squibb & Sons Inc | Rekombinante fibrinketten, fibrin und fibrinhomologe |
US5681278A (en) | 1994-06-23 | 1997-10-28 | Cormedics Corp. | Coronary vasculature treatment method |
EP1004293A3 (de) * | 1994-10-12 | 2001-10-04 | Focal, Inc. | Zielgerichtete Verabreichung mittels biologisch abbaubarer Polymere |
US5814066A (en) | 1994-12-23 | 1998-09-29 | The University Of Virginia Patent Foundation | Reduction of femoral arterial bleeding post catheterization using percutaneous application of fibrin sealant |
FR2732357B1 (fr) | 1995-03-31 | 1997-04-30 | Rhone Poulenc Rorer Sa | Vecteurs viraux et utilisation pour le traitement des desordres hyperproliferatifs, notamment de la restenose |
US5653744A (en) | 1995-04-27 | 1997-08-05 | Khouri Biomedical Research, Inc. | Device and method for vascular anastomosis |
US5766584A (en) | 1995-06-02 | 1998-06-16 | Massachusetts Institute Of Technology | Inhibition of vascular smooth muscle cell proliferation with implanted matrix containing vascular endothelial cells |
US5713891A (en) | 1995-06-02 | 1998-02-03 | Children's Medical Center Corporation | Modified solder for delivery of bioactive substances and methods of use thereof |
AU716005B2 (en) | 1995-06-07 | 2000-02-17 | Cook Medical Technologies Llc | Implantable medical device |
WO1996040174A1 (en) * | 1995-06-07 | 1996-12-19 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
JPH0982495A (ja) * | 1995-09-18 | 1997-03-28 | Toshiba Corp | プラズマ生成装置およびプラズマ生成方法 |
US5752974A (en) | 1995-12-18 | 1998-05-19 | Collagen Corporation | Injectable or implantable biomaterials for filling or blocking lumens and voids of the body |
EP0984813A1 (de) * | 1997-05-13 | 2000-03-15 | Stuart D. Edwards | Verfahren und vorrichtung zur globalen medizinische behandlung |
US20020164374A1 (en) * | 1997-10-29 | 2002-11-07 | John Jackson | Polymeric systems for drug delivery and uses thereof |
US6153252A (en) * | 1998-06-30 | 2000-11-28 | Ethicon, Inc. | Process for coating stents |
US6632457B1 (en) | 1998-08-14 | 2003-10-14 | Incept Llc | Composite hydrogel drug delivery systems |
US6544541B1 (en) * | 1999-06-02 | 2003-04-08 | Cardiovascular Solutions, Inc. | Devices and compounds for treating arterial restenosis |
CA2396628A1 (en) * | 2000-01-25 | 2001-08-02 | Edwards Lifesciences Corporation | Delivery systems for treatment of restenosis and anastomotic intimal hyperplasia |
-
2001
- 2001-01-25 CA CA002396628A patent/CA2396628A1/en not_active Abandoned
- 2001-01-25 EP EP01905081A patent/EP1250166B1/de not_active Expired - Lifetime
- 2001-01-25 WO PCT/US2001/002563 patent/WO2001054748A1/en active IP Right Grant
- 2001-01-25 AT AT01905081T patent/ATE460951T1/de not_active IP Right Cessation
- 2001-01-25 DE DE60141567T patent/DE60141567D1/de not_active Expired - Lifetime
- 2001-01-25 US US09/771,480 patent/US6730313B2/en not_active Expired - Lifetime
- 2001-01-25 AU AU32999/01A patent/AU775590B2/en not_active Ceased
- 2001-01-25 JP JP2001554731A patent/JP2003520830A/ja not_active Withdrawn
-
2004
- 2004-04-02 US US10/816,680 patent/US6991804B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU775590B2 (en) | 2004-08-05 |
US6730313B2 (en) | 2004-05-04 |
JP2003520830A (ja) | 2003-07-08 |
EP1250166A1 (de) | 2002-10-23 |
EP1250166B1 (de) | 2010-03-17 |
CA2396628A1 (en) | 2001-08-02 |
WO2001054748A1 (en) | 2001-08-02 |
US20020026236A1 (en) | 2002-02-28 |
DE60141567D1 (de) | 2010-04-29 |
US20040202711A1 (en) | 2004-10-14 |
US6991804B2 (en) | 2006-01-31 |
AU3299901A (en) | 2001-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE460951T1 (de) | Freisetzungssysteme zur behandlung von restenose und anastomotischer intimaler hyperplasie | |
CY1120313T1 (el) | Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει βιταμινη d και κορτικοστεοειδες | |
WO2003082188A3 (en) | Methods and drug delivery systems for the treatment of orofacial diseases | |
DE69803360D1 (de) | Anwendungsformen zur behandlung der männlichen erektilen dysfunktion | |
WO2005027842A8 (en) | Combinations of drugs for the treatment of neoplasms | |
ATE457166T1 (de) | Orale zusammensetzungen zur behandlung von diabetes | |
BR0317747A (pt) | Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave | |
BR0209658A (pt) | Derivados de 4-amino-5-fenil-7-1ciclobutil-pirrolo [2,3-d] pirimidina | |
ATE316786T1 (de) | Behandlung von mukositis | |
WO2002100390A3 (en) | Improved method of treating the syndrome of coronary heart disease risk factors in humans | |
ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
CY1107615T1 (el) | Θεραπευτικοι συνδυασμοι αντιυπερτασικων και αντιαγγειογενετικων παραγοντων | |
HUP0203590A2 (hu) | Gyógyszerkészítmény a csonttömeg csökkenésével járó betegségek kezelésére | |
CY1109861T1 (el) | Διαδερμικο θεραπευτικο συστημα για την ασθενεια του παρκινσον που προκαλει υψηλα επιπεδα πλασματος της ροτιγοτινης | |
ATE265213T1 (de) | Noribogain zur behandlung von schmerzen und drogenabhängigkeit | |
BR0109446A (pt) | Medicamento para a aplicação intracorpórea, uso de um xanteno halogenado, composição farmacêutica, e, método de tratamento | |
WO2006023130A3 (en) | Biodegradable controlled release bioactive agent delivery device | |
ATE288743T1 (de) | Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist | |
DE602004012816D1 (de) | Selbstexpandierbarer Stent und Stenteinbringungssystem zur Behandlung von Gefässerkrankungen | |
EA201100544A1 (ru) | Применение комбинации опиоидного агониста и конъюгата полимер-опиоидный антагонист для изготовления лекарственного средства для лечения и предупреждения боли | |
BR0306858A (pt) | Sistemas de liberação de drogas para a prevenção e tratamento de doenças vasculares compreendendo rapamicina e derivados da mesma | |
ATE515288T1 (de) | Carboxy-amido-triazole zur lokalisierten behandlung von augenerkrankungen | |
DE60233944D1 (de) | Wirkstoffabgabesysteme | |
BR0205722A (pt) | Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor | |
ATE286384T1 (de) | Formulierung mit verzögerter freisetzung enthaltend kollagen und glykosaminoglykan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |